TY - JOUR T1 - Modeling COVID-19 Aerosol Transmission in Primary Schools JF - medRxiv DO - 10.1101/2021.12.08.21267499 SP - 2021.12.08.21267499 AU - Tessa Swanson AU - Seth Guikema AU - James Bagian AU - Claire Payne Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/12/09/2021.12.08.21267499.abstract N2 - Schools must balance public health, education, and social risks associated with returning to in-person learning. These risks are compounded by the ongoing uncertainty about vaccine availability and uptake for children under 12 years of age. In this paper, we show how the risk of infections that result directly from in-class aerosol transmission within an elementary school population can be estimated in order to compare the effects of different countermeasures. We compare the effectiveness of these countermeasures in reducing transmission including required masking at three levels of mask effectiveness, improving room airflow exchange rates, weekly testing of the students, and lunch partitioning. Our results show that multiple layers of interventions are necessary to keep in-class infections relatively low. These results can inform school administrators about how these interventions can help manage COVID-19 spread within their own elementary school populations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by internal University of Michigan funds through the University of Michigan College of Engineering COVID skunkworks program.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data from actual schools is used in this paper. The code used in the simulation underlying this paper will be made available to others via a public reponsitory after acceptance of the peer-reviewed journal of this paper. ER -